What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Big buy
Lynx1 Capital Management LP: large open-market buy of CGEM
$3.6M open-market purchase by Lynx1 Capital Management LP, 10% Owner at Cullinan Therapeutics,Inc., filed October 10, 2025. Learn more
Feed status Last SEC check:Loading Last Filing: Loading
View CGEM
Access Free feed
Quick read What does this view show?
Why it matters
Read the SEC filing
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Role, size, timing
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Key insider views at a glance
Big BuyCGEM
$21.00-1.45% today
Lynx1 Capital Management LP · 10% Owner at Cullinan Therapeutics,Inc.
$3.6M
Lynx1 Capital Management LP bought $3.6M of CGEM (Cullinan Therapeutics,Inc.).
Insider purchase
Transaction details
Lynx1 Capital Management LP, a 10% beneficial owner, reported a $3.6M open-market purchase equal to 0.39% of CGEM's market cap.
Lynx1 Capital Management LP (10% Owner) bought 556,300 shares of CGEM, Cullinan Therapeutics,Inc., Healthcare ($918.1M market cap), at $6.46 per share on October 8, 2025 for a total of $3.6M (0.39% of the market cap).
Lynx1 Capital Management LP
10% Owner
Purchase value$3.6M
Shares purchased556,300
Price per share$6.46 per share
- % of market cap
- 0.39%
- Trade date
- October 8, 2025
- Filed
- October 10, 2025
- Filing delay
- 2 days
Permalink https://bluecollarpicks.com/insider-trading/CGEM/buy/61027
Market context
CGEM market snapshot
Current price$21.00
1-day change-1.45%
Market cap$918.1M
SectorHealthcare
Next earningsNovember 4, 2026
$21.00
Current price$21.00
Analyst target$31.63 (+111.7%)
Last enriched September 11, 2026 at 7:34 AM EDT.
Filings
Recent insider trades
Status Loading
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
| $17.2K | |||
| $125.4K | |||
| $17.2K | |||
| Not reported | |||
| $25.2K | |||
| $52.1K | |||
| $24.5K | |||
Sell CEO | $195.6K | ||
Sell Officer | $66.3K | ||
Sell Officer | $52.1K | ||
Sell Officer | $67.9K | ||
| $34.4K | |||
| $114.4K | |||
| Not reported | |||
| $51K | |||
Sell Officer | $51K | ||
Sell CEO | $223.1K | ||
Sell CFO | $59.9K | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Grant CEO | $0 | ||
Grant Officer | $0 | ||
Grant CFO | $0 | ||
Grant CFO | $0 | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Sell Officer | $5K | ||
| $49.2K | |||
Grant CFO | $175 | ||
Sell CEO | $99.3K | ||
Sell Officer | $13.5K | ||
Sell Officer | $33.7K | ||
Sell Officer | $44.8K | ||
Sell Officer | $28K | ||
Sell Officer | $49.2K | ||
Big Buy 10% Owner | $1.4M | ||
Buy 10% Owner | $114K | ||
| This filing | Big Buy 10% Owner | $3.6M | |
Sell Officer | $32K | ||
Sell Officer | $32K | ||
Sell Officer | $41.8K | ||
Sell CEO | $106.9K | ||
Sell Officer | $50K | ||
$17.2K
$125.4K
$17.2K
Not reported
$25.2K
$52.1K
$24.5K
$195.6K
Sell CEO
$66.3K
Sell Officer
$52.1K
Sell Officer
$67.9K
Sell Officer
$34.4K
$114.4K
Not reported
$51K
$51K
Sell Officer
$223.1K
Sell CEO
$59.9K
Sell CFO
Grant Officer
Grant Officer
$0
Grant CEO
Grant Officer
Grant CFO
Grant CFO
Grant Officer
Grant Officer
Sell Officer
$49.2K
$175
Grant CFO
$99.3K
Sell CEO
$13.5K
Sell Officer
$33.7K
Sell Officer
$44.8K
Sell Officer
$28K
Sell Officer
$49.2K
Sell Officer
Big Buy 10% Owner
Buy 10% Owner
Big Buy 10% Owner
$32K
Sell Officer
$32K
Sell Officer
$41.8K
Sell Officer
$106.9K
Sell CEO
$50K
Sell Officer
Cluster detail
Cluster members
Ticker context
Ticker summary
Recent insider activity for this company.
Insider detail
Insider activity
Recent transactions grouped by reporting owner.
Filters
Filters
Weekly recap
Get the easier version in your inbox.
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
CSV exports are becoming a paid feature.
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.